Famciclovir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 11 USDMF, 5 JDMF, 7 EU WC, 13 KDMF, 7 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

116 FDF Dossiers, 27 FDA Orange Book, 45 Europe, 9 Canada, 21 Australia, 6 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 2 Seqens, 10 DKSH, 4 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 4 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 37 Direct Compression, 27 Solubilizers, 27 Thickeners and Stabilizers, 27 Controlled & Modified Release, 26 Granulation, 23 Lubricants & Glidants, 16 Co-Processed Excipients, 15 Topical, 15 Film Formers & Plasticizers, 12 Parenteral, 9 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 5 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

5 NEWS #PharmaBuzz

5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 62 Finished Drug Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

13 Health Canada Patents

13 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 USP, 7 Others

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination

08 Sep 2021

// BIOSPACE

Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination

08 Sep 2021

// BUSINESSWIRE

EMA Approved Famciclovir List of nationally authorised medicinal products

09 Nov 2018

// EMA

Enforcement Report - Week of March 29, 2017

29 Mar 2017

// FDA

Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

02 May 2015

// Eric Palmer FIERCE PHARMA MFG

Famciclovir

Famciclovir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers

11 USDMF

5 JDMF

7 EU WC

13 KDMF

7 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

116 FDF Dossiers

27 FDA Orange Book

45 Europe

9 Canada

21 Australia

6 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 SPI Pharma

2 Seqens

10 DKSH

4 Faran Shimi Pharmaceutical

5 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

12 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 ACG Worldwide

5 Actylis

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

28 BASF

1 Clariant

10 Corel Pharma Chem

7 DFE Pharma

1 Finar

12 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

3 Novo Excipients

5 Pharmatrans-Sanaq

4 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders

48 Coating Systems & Additives

40 Disintegrants & Superdisintegrants

37 Direct Compression

27 Solubilizers

27 Thickeners and Stabilizers

TABLET;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons